hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Gavi steps up child vaccine funding programme

Author: Mark Tran, Guardian [UK], Published on: 27 September 2011

The Global Alliance for Vaccines and Immunisation (Gavi) said...it will provide more funding for developing countries to introduce vaccines against severe diarrhoea and pneumonia, two leading causes of child deaths. Gavi, a public-private partnership to help the world's poorest countries obtain vital vaccines and reduce child mortality, described the rollout of rotavirus and pneumococcal vaccines as its biggest commitment of funds to date...The vaccines for pneumonia will come from GlaxoSmithKline (GSK) and Wyeth [part of Pfizer] and the target price for them will be $3.50, 90% less than when sold in the west. The vaccines for diarrhoea will be provided by GSK and Merck, again at a greatly reduced price of $5.

Read the full post here

Related companies: GlaxoSmithKline Merck Pfizer Wyeth (part of Pfizer)